Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.9093 USD | +2.50% | -1.47% | -34.11% |
26/04 | Bluebird bio Gets Nasdaq Notice for Late Filing of Annual Report | MT |
27/03 | Wells Fargo Trims Price Target on Bluebird Bio to $3 From $4, Maintains Equalweight Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-34.11% | 175M | |
-1.17% | 104B | |
+2.87% | 97.47B | |
+2.13% | 22.25B | |
-14.77% | 21.68B | |
-8.79% | 18.2B | |
-39.98% | 17.02B | |
-13.21% | 16.36B | |
+8.55% | 14.39B | |
+35.75% | 12.37B |
- Stock Market
- Equities
- BLUE Stock
- News bluebird bio, Inc.
- Morgan Stanley Adjusts Price Target on bluebird bio to $10 From $11, Maintains Underweight Rating